Sumitomo Pharma Investor Relations Material
Latest events
Q3 2025
Sumitomo Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Sumitomo Pharma Co Ltd
Access all reports
Sumitomo Pharma Co., Ltd. is a Japanese pharmaceutical company engaged in the research, development, manufacturing, and marketing of prescription drugs and medical solutions. The company focuses on therapeutic areas such as psychiatry, neurology, oncology, and infectious diseases. The company is headquartered in Osaka, Japan, and its shares are listed on the Tokyo Stock Exchange (TSE).
Key slides for Sumitomo Pharma Co Ltd
Q3 2025
Sumitomo Pharma Co Ltd
Q3 2025
Sumitomo Pharma Co Ltd
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
4506
Country
🇯🇵 Japan